OppenheimJ.J. and RuscettiF.W.. 1997. Cytokines. In Medical Immunology, ed. (ninth) StitesD. P.TerrA. I. and ParslowT. G.. Appleton and Lange Stamford, Connecticut, p. 146.
2.
AcharyaA. and SinghS.M.. 2001. Effect of TNFα on the induction of apoptosis in murine macrophage:role of ICE. Int. J. Immunopathol. Pharmacol.14:5.
3.
ContiP.KempurajD. and TheoharidesT.C.. 2001. Mechanism by which IL-16 generated by mast cells mediates allergic inflammation. Int. J. Immunopathol. Pharmacol.14:1.
4.
FrydasS.RallisT.TheodoridisI.PatsikasM.N.TrakatellisC.Di GioacchinoM. and FelacoM.. 2000. Trichinella spiralis infection is mediated by MCP-1 and MIP-2, while Echinococcus granulosus is mediated strongly by MCP-1, but not MIP-2. Int. J. Immunopathol. Pharmacol.13:21.
5.
ConfortiA.LussignoliS.BertaniS.OrtolaniR.CuzzolinL.BenoniG. and BellaviteP.. 2001. Cytokine and nitric oxide levels in a rat model of immunologic protection from adjuvant-induced arthritis. Int. J. Immunopathol. Pharmacol.14:153.
6.
Di LuzioS.FelacoS. M.BarbacaneR. C.FrydasS.GrilliA.CastellaniM. L.MacriM. A.Di GioacchinoM.De LutiisM. A.MerlittiD.MasciS.Di GiulioC.CacchioM. and RealeM.. 2001. Effects of 50 Hz sinusoidal electromagnetic fields on MCP-1 and RANTES generated from activated human macrophages. Int. J. Immunopathol. Pharmacol.14:169.
7.
StefanoG. B.CadetP.FimianiC. and MagazineH. I.. 2001. Morphine stimulates iNOS expression via a rebound from inhibition in human macrophages: Nitric Oxide involvement. Int. J. Immunopathol. Pharmacol.14:129.
8.
Di GioacchinoM.VernaN.CavalluciE.PaoliniF.CarusoR.GranaM.SchiavoneC.Di IorioA.RamandoS.RealeM.PaganelliR. and TheoharidesT. C.. 2002. Steroid and antihistamines modulates RANTES release in cultures peripheral blood mononuclear cells of atopic patients. Int. J. Immunopathol. Pharmacol.15:27.
9.
YoshinoS.HayashiH.TanedaS.TakanoH.SagaiM. and MoriY.. 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol.15:13.
10.
KasaharaS.FugoH.CooperE. L. and WagoH.. 2001. Preliminary evidence of modulating Th1 cytokine after allergen challenge. Int. J. Immunopathol. Pharmacol.14:63.
11.
KozlowskakK.ChichorekM. and ZarzecznaM.. 2000. Implication of macrophage NO and cytokine secretion in the cytotoxicity of transplantable melanomas as regards the progression of these tumors. Int. J. Immunopathol. Pharmacol.13:69.
12.
BelliF.CapriaA.MoraitiA.RossiS. and RossiP. 2000. Cytokines assay in peripheral blood and bronchoalveolar lavage in the diagnosis and staging of pulmonary granulomatous diseases. Int. J. Immunopathol. Pharmacol.13:61.
13.
SongE.ChenJ.AntusB.WangM.XieY.OuyangN.YaoH. and ExtonM. S.. 2000. Interleukin-2 enhances susceptibility of colon cancer cells to FasR-mediated apoptosis by up-regulating Fas receptor level and down-regulating FAP-1 expression. Int. J. Immunopathol. Pharmacol.13:113.
14.
BiswasS. K. and SodhiA.. 2002. Effect of monocyte chemoattractant protein-1 on murine bone marrow cells: proliferation, colony forming ability signal transduction pathway involved. Int. J. Immunopathol. Pharmacol.15:183.
15.
TrubianiO.GuarnieriS.PaganelliR. and Di PrimioR.. 2002. Involvement of caspase-3 in the cleavage of terminal transferase. Int. J. Immunopathol. Pharmacol.15:201.
16.
ChiappiniE.PeruzziM.GalliL.CalabriG. and de MartinoM.. 2002. Dose-related IL-6 overproduction by phenobarbital-incubated peripheral blood mononuclear cells in a child with antconvulsant hypersensitivity syndrome. Int. J. Immunopathol. Pharmacol.15:239.
17.
ParrellaO.ParrellaM.CusumanoV.IbelloU.SbregliaC.De SenaR. and PerrellaA.. 2002. Interleukin-10 and transforming growth factor beta 1 in hepatic fibrosis. Int. J. Immunopathol. Pharmacol.15:243.
18.
HuangM.BerryJ.KandereK.LytinasM.KaralisK. and TheoharidesT. C.. 2002. Mast cell deficient w/wv mice lack stress-induced increse in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol.15:249.
19.
RallisT. S.FrydasS.SoubasisN.Adamama-MoraitouK. K. and TontisD.. 2002. Monocyte chemotactic protein-1 in a randomized placebo-controlled study of canine plasmacytic-lymphocytic colitis. Int. J. Immunopathol. Pharmacol.15:107.
20.
BrunoG.AndreozziP.GrafU.SantangeloG.BaruccoM.BrunoA. and BracchittaS.. 2002. Cetirizine, a second-generation H1 antagonist, modulates RANTES and MCP-1 levels in allergic rhinitis. Int. J. Immunopathol. Pharmacol.15:113.
21.
WolkK.KunzS.AsadullahK. and SabatR.. 2002. Cutting edge: immune cells as sources and targets of the IL-10 family members?J. Immunol.1:5397.
22.
DumoutrierL. and RenauldJ. C.. 2002. Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur. Cytokine Netw. 13:5.
23.
DumotrierL.LeemansC.LejeuneD.KotenkoS. V. and RenauldJ. C.. 2001. Cutting Edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J. Immunol.1:3545.
24.
GallagherG.DickensheetsH.EskdaleJ.IzotovaL. S.MirochnitchenkoO. V.PeatJ. D.VazquezN.PestkaS.DonnellyR. P. and KotenkoS. V.. 2000. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun. 1:442.
25.
LiaoY. C.LiangW. G.ChenF. W.HsuJ. H.YangJ. J. and ChangM. S.. 2002. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J. Immunol.15:4288.